Stock News: Defence Therapeutics - From the Lab to millions of living rooms in the USA

Short infotainment formats are popular among viewers - for example, before the news or between two movies. The Canadian biotech startup Defence Therapeutics has now been chosen by the series "Viewpoint with Dennis Quaid" as a partner for a series on the opportunities and limitations of biotechnology. For the Company, which is aiming for the Nasdaq, the associated publicity can only be beneficial. What remains decisive, however, is what happens behind the camera. Groundbreaking research is currently underway.

Den vollständigen Artikel lesen ...